ORALLY-ADMINISTERED ENALAPRIL FOR INFANTS WITH CONGESTIVE HEART-FAILURE - A DOSE-FINDING STUDY

被引:22
作者
LLOYD, TR
MAHONEY, LT
KNOEDEL, D
MARVIN, WJ
ROBILLARD, JE
LAUER, RM
机构
[1] UNIV IOWA, COLL MED, DEPT PEDIAT, DIV PEDIAT CARDIOL, IOWA CITY, IA 52242 USA
[2] UNIV IOWA, COLL MED, DEPT PEDIAT, DIV NEPHROL, IOWA CITY, IA 52242 USA
关键词
D O I
10.1016/S0022-3476(89)80715-2
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:650 / 654
页数:5
相关论文
共 18 条
[1]   GUIDELINES FOR VASODILATOR THERAPY OF CONGESTIVE-HEART-FAILURE IN INFANTS AND CHILDREN [J].
ARTMAN, M ;
GRAHAM, TP .
AMERICAN HEART JOURNAL, 1987, 113 (04) :994-1005
[2]  
BENGUR A R, 1988, Journal of the American College of Cardiology, V11, p28A
[3]   ENALAPRIL MALEATE AND A LYSINE ANALOG (MK-521) IN NORMAL VOLUNTEERS - RELATIONSHIP BETWEEN PLASMA DRUG LEVELS AND THE RENIN-ANGIOTENSIN SYSTEM [J].
BIOLLAZ, J ;
SCHELLING, JL ;
COMBES, BJD ;
BRUNNER, DB ;
DESPONDS, G ;
BRUNNER, HR ;
ULM, EH ;
HICHENS, M ;
GOMEZ, HJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (03) :363-368
[4]   ACUTE AND LONG-TERM EFFECTS OF ENALAPRIL ON THE CARDIOVASCULAR-RESPONSE TO EXERCISE AND EXERCISE TOLERANCE IN PATIENTS WITH CONGESTIVE HEART-FAILURE [J].
CREAGER, MA ;
MASSIE, BM ;
FAXON, DP ;
FRIEDMAN, SD ;
KRAMER, BL ;
WEINER, DA ;
RYAN, TJ ;
TOPIC, N ;
MELIDOSSIAN, CD .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 6 (01) :163-170
[5]   THE PHARMACOKINETICS OF ENALAPRIL IN HOSPITALIZED-PATIENTS WITH CONGESTIVE-HEART-FAILURE [J].
DICKSTEIN, K ;
TILL, AE ;
AARSLAND, T ;
TJELTA, K ;
ABRAHAMSEN, AM ;
KRISTIANSON, K ;
GOMEZ, HJ ;
GREGG, H ;
HICHENS, M .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 23 (04) :403-410
[6]   EFFECTS OF ENALAPRIL, A NEW CONVERTING ENZYME-INHIBITOR, IN HYPERTENSION [J].
FERGUSON, RK ;
VLASSES, PH ;
SWANSON, BN ;
MOJAVERIAN, P ;
HICHENS, M ;
IRVIN, JD ;
HUBER, PB .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (01) :48-53
[7]   TREATMENT OF CONGESTIVE HEART-FAILURE BY ALTERING LOADING CONDITIONS OF THE HEART [J].
FRIEDMAN, WF ;
GEORGE, BL .
JOURNAL OF PEDIATRICS, 1985, 106 (05) :697-706
[8]  
HITCHENS M, 1981, LIGAND Q, V4, P43
[9]   SAFETY PROFILES OF THE ANGIOTENSIN CONVERTING ENZYME-INHIBITORS CAPTOPRIL AND ENALAPRIL [J].
IRVIN, JD ;
VIAU, JM .
AMERICAN JOURNAL OF MEDICINE, 1986, 81 (4C) :46-50
[10]   CLINICAL PHARMACOKINETICS OF THE ANGIOTENSIN CONVERTING ENZYME-INHIBITORS - A REVIEW [J].
KUBO, SH ;
CODY, RJ .
CLINICAL PHARMACOKINETICS, 1985, 10 (05) :377-391